The after-hours PTS trading price was ¥88.5, down ¥0.5 from the previous day. According to the earnings summary, sales for the interim period of the fiscal year ending December 2026 fell 80.9% to ¥33.14 million, while the company posted a net loss of ¥323.11 million, making continued financing a challenge.
D.Western Therapeutics Institute, Inc.'s after-hours PTS trading price is currently ¥88.5, with volume of 400 shares as of 23:48, representing a change of -0.56% from the previous day's closing price. Sections covering the message board and breakdown of cash equity trading are also included.
According to a summary of the earnings report, sales for the interim period of the fiscal year ending December 2026 fell 80.9% year on year to ¥33.14 million. Although the company made progress in reducing expenses, it posted a net loss of ¥323.11 million. A material event related to the going concern assumption exists, and continued financing is identified as a challenge.
A summary of recent earnings trends shows that profit margins have remained negative over the past 12 quarters, while the equity ratio has been trending upward. Although the year-on-year decline in EPS has narrowed, sales growth remains weak and interest-bearing debt has remained high.